Jupiter Life Line Hospitals Limited (JLHL) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Jupiter Life Line Hospitals Limited (JLHL) has a cash flow conversion efficiency ratio of -0.036x as of March 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-129.72 Million ≈ $-1.40 Million USD) by net assets (Rs3.64 Billion ≈ $39.36 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Jupiter Life Line Hospitals Limited balance sheet independence to measure how much of total assets are equity-financed.
Jupiter Life Line Hospitals Limited - Cash Flow Conversion Efficiency Trend (2020–2025)
This chart illustrates how Jupiter Life Line Hospitals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Jupiter Life Line Hospitals Limited (JLHL) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Jupiter Life Line Hospitals Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jupiter Life Line Hospitals Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Junee Limited Ordinary Shares
NASDAQ:JUNE
|
-0.059x |
|
Colombier Acquisition Corp. II
NYSE:CLBR
|
-0.003x |
|
INFOM
KLSE:0265
|
0.045x |
|
CMC Corp
VN:CMG
|
0.060x |
|
St Augustine Gold and Copper Ltd
TO:SAU
|
-0.002x |
|
Computer Modelling Group Ltd.
TO:CMG
|
0.000x |
|
TFE Co. Ltd.
KQ:425420
|
0.015x |
|
AC Immune Ltd
NASDAQ:ACIU
|
-0.522x |
Annual Cash Flow Conversion Efficiency for Jupiter Life Line Hospitals Limited (2020–2025)
The table below shows the annual cash flow conversion efficiency of Jupiter Life Line Hospitals Limited from 2020 to 2025. For the full company profile with market capitalisation and key ratios, see JLHL stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs13.56 Billion ≈ $146.67 Million |
Rs2.53 Billion ≈ $27.39 Million |
0.187x | +90.61% |
| 2024-03-31 | Rs11.69 Billion ≈ $126.39 Million |
Rs1.15 Billion ≈ $12.39 Million |
0.098x | -69.57% |
| 2023-03-31 | Rs3.64 Billion ≈ $39.36 Million |
Rs1.17 Billion ≈ $12.67 Million |
0.322x | -32.20% |
| 2022-03-31 | Rs2.88 Billion ≈ $31.19 Million |
Rs1.37 Billion ≈ $14.81 Million |
0.475x | -5.17% |
| 2021-03-31 | Rs2.46 Billion ≈ $26.65 Million |
Rs1.23 Billion ≈ $13.35 Million |
0.501x | +142.96% |
| 2020-03-31 | Rs2.37 Billion ≈ $25.60 Million |
Rs487.93 Million ≈ $5.28 Million |
0.206x | -- |
About Jupiter Life Line Hospitals Limited
Jupiter Life Line Hospitals Limited, a multi-specialty hospital, provides health care services under the Jupiter brand in India. The company offers treatments in the areas of bariatric surgery, breast care center, cardiac surgery, cardiology, chest medicine, dental care, dermatology, endocrinology and diabetes, ENT, gastroenterology, general surgery and minimal access surgery, hematology and BMT,… Read more